Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 28

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban

Abrol, Neha, de Tombe, Pieter P., Robia, Seth L. · 2015 · Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m114.630319

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 48

  1. Lipskaia, 2009, Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation, Pflugers Arch, 457, 673, 10.1007/s00424-007-0428-7 · DOI
  2. Periasamy, 2001, SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility, J. Mol. Cell. Cardiol, 33, 1053, 10.1006/jmcc.2001.1366 · DOI · Paper page
  3. Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ. Res, 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
  4. Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
  5. Hagemann, 2002, Dual site phospholamban phosphorylation and its physiological relevance in the heart, Trends Cardiovasc. Med, 12, 51, 10.1016/S1050-1738(01)00145-1 · DOI
  6. Wegener, 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation, J. Biol. Chem, 264, 11468, 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
  7. Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
  8. Schmitt, 2009, Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI · Paper page
  9. Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
  10. Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am. Heart J, 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
  11. Landstrom, 2011, PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing, Am. Heart J, 161, 165, 10.1016/j.ahj.2010.08.001 · DOI
  12. Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  13. DeWitt, 2006, Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy, J. Am. Coll. Cardiol, 48, 1396, 10.1016/j.jacc.2006.07.016 · DOI
  14. Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · DOI
  15. van Rijsingen, 2014, Outcome in phospholamban R14del carriers: results of a large multicentre cohort study, Circ. Cardiovasc. Genet, 7, 455, 10.1161/CIRCGENETICS.113.000374 · DOI · Paper page
  16. Jefferies, 2010, Dilated cardiomyopathy, Lancet, 375, 752, 10.1016/S0140-6736(09)62023-7 · DOI · Paper page
  17. Dellefave, 2010, The genetics of dilated cardiomyopathy, Curr. Opin. Cardiol, 25, 198, 10.1097/HCO.0b013e328337ba52 · DOI · Paper page
  18. Parvari, 2012, The mutations associated with dilated cardiomyopathy, Biochem. Res. Int, 2012, 639250, 10.1155/2012/639250 · DOI
  19. Ceholski, 2012, Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A, J. Biol. Chem, 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
  20. Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
  21. Paterlini, 2005, The α-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation, Biophys. J, 88, 3243, 10.1529/biophysj.104.054460 · DOI
  22. Yu, 2013, Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy, Biochim. Biophys. Acta, 1828, 2444, 10.1016/j.bbamem.2013.07.003 · DOI
  23. Yu, 2014, Secondary structure, backbone dynamics, and structural topology of phospholamban and its phosphorylated and Arg9Cys-mutated forms in phospholipid bilayers utilizing 13C and 15N solid-state NMR spectroscopy, J. Phys. Chem. B, 118, 2124, 10.1021/jp500316s · DOI · Paper page
  24. Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem, 283, 28996, 10.1074/jbc.M804782200 · DOI
  25. Wegener, 1984, Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits, J. Biol. Chem, 259, 1834, 10.1016/S0021-9258(17)43484-3 · DOI · Paper page
  26. Hasenfuss, 1998, Animal models of human cardiovascular disease, heart failure and hypertrophy, Cardiovasc. Res, 39, 60, 10.1016/S0008-6363(98)00110-2 · DOI · Paper page
  27. Pattison, 2008, Phospholamban overexpression in transgenic rabbits, Transgenic Res, 17, 157, 10.1007/s11248-007-9139-2 · DOI
  28. Bers, 2002, Cardiac excitation-contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
  29. Hou, 2010, Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer, J. Mol. Biol, 402, 210, 10.1016/j.jmb.2010.07.023 · DOI
  30. Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem, 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
  31. Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ. Res, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
  32. Kelly, 2008, Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells, J. Biol. Chem, 283, 12202, 10.1074/jbc.M707590200 · DOI
  33. Autry, 1998, High-level coexpression of the canine cardiac calcium pump and phospholamban in Sf21 insect cells, Ann. N. Y. Acad. Sci, 853, 92, 10.1111/j.1749-6632.1998.tb08259.x · doi:10.1111/j.1749-6632.1998.tb08259.x
  34. Domeier, 2009, Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure, J. Physiol, 587, 5197, 10.1113/jphysiol.2009.177576 · DOI
  35. Pallikkuth, 2013, Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase, Biophys. J, 105, 1812, 10.1016/j.bpj.2013.08.045 · DOI · Paper page
  36. Abrol, 2014, Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex, J. Biol. Chem, 289, 25855, 10.1074/jbc.M114.562579 · DOI
  37. Zal, 2004, Photobleaching-corrected FRET efficiency imaging of live cells, Biophys. J, 86, 3923, 10.1529/biophysj.103.022087 · DOI · Paper page
  38. Förster, 1948, Intermolecular energy migration and fluorescence, Ann. Phys, 2, 55, 10.1002/andp.19484370105 · DOI · Paper page
  39. Li, 1999, A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban, Biophys. J, 76, 2587, 10.1016/S0006-3495(99)77411-4 · DOI
  40. Robia, 2005, Phospholamban pentamer quaternary conformation determined by in-gel fluorescence anisotropy, Biochemistry, 44, 4302, 10.1021/bi0478446 · DOI
  41. Runnels, 1995, Theory and application of fluorescence homotransfer to melittin oligomerization, Biophys. J, 69, 1569, 10.1016/S0006-3495(95)80030-5 · DOI · Paper page
  42. Fujii, 1989, Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation, J. Biol. Chem, 264, 12950, 10.1016/S0021-9258(18)51579-9 · DOI · Paper page
  43. King, 2014, The FRET signatures of noninteracting proteins in membranes: simulations and experiments, Biophys. J, 106, 1309, 10.1016/j.bpj.2014.01.039 · DOI
  44. Schröder, 2008, Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations, Curr. Opin. Pharmacol, 8, 153, 10.1016/j.coph.2007.12.012 · DOI
  45. Gramolini, 2008, Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses, Mol. Cell. Proteomics, 7, 519, 10.1074/mcp.M700245-MCP200 · DOI
  46. Smeazzetto, 2013, Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity, PLoS One, 8, e52744, 10.1371/journal.pone.0052744 · DOI
  47. Dong, 2014, Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation, Biochem. Biophys. Res. Commun, 449, 196, 10.1016/j.bbrc.2014.04.166 · DOI · Paper page
  48. Choudhary, 2002, Heart failure, oxidative stress, and ion channel modulation, Congest. Heart Fail, 8, 148, 10.1111/j.1527-5299.2002.00716.x · DOI

Cited by

See all 28

Metadata

Authors
Abrol, N., de Tombe, P. P., & Robia, S. L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2015-03
Volume
290
Issue
11
Pages
7130-7140
ISSN
0021-9258
Cited by
28
References
3
Language
en
Licence
Funders
National Institutes of Health (HL-092321, HL-62426, HL-75494)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban. https://app.cochat.ai/papers/10.1074/jbc.m114.630319
The paper
Abrol, N., de Tombe, P. P., & Robia, S. L. (2015). Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m114.630319

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.